Thursday, June 3, 2021

Serum Institute of India seeks indemnity against liabilities: Sources

Serum Institute of India (SII), the company manufacturing Covishield -- the local version of the Oxford–AstraZeneca COVID-19 vaccine, has sought indemnity protection against liabilities, news agency ANI reported quoting sources.

from IndiaTV India: Google News Feed https://ift.tt/3vSx5Ss
via

No comments:

Post a Comment

Please do not enter spam link in the comment box. Suggestions are invited for improvement.

Republic Day 2024: French band, marching contingent and Rafale jets participate in parade | WATCH

Republic Day 2024 : As India's 75th Republic Day Parade kicked off in the national capital, a 30-member band contingent and a marching c...